%Responders to A33 in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %48.5915 (43.8967,53.2864)
by IL-2 ELISpot (95% CI): %20.1878 (16.4319,23.9437)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %19.9531 (16.1972,23.9437)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %71.3216 (66.5698,76.0734)
